These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29140542)

  • 1. Perioperative von Willebrand factor dynamics are associated with liver regeneration and predict outcome after liver resection.
    Starlinger P; Pereyra D; Haegele S; Braeuer P; Oehlberger L; Primavesi F; Kohler A; Offensperger F; Reiberger T; Ferlitsch A; Messner B; Beldi G; Staettner S; Brostjan C; Gruenberger T
    Hepatology; 2018 Apr; 67(4):1516-1530. PubMed ID: 29140542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bivalent property of intra-platelet VWF in liver regeneration and HCC recurrence: A prospective multicenter study.
    Aryal B; Yamakuchi M; Shimizu T; Kadono J; Furoi A; Gejima K; Takenouchi K; Komokata T; Hashiguchi T; Imoto Y
    Cancer Biomark; 2019; 26(1):51-61. PubMed ID: 31322547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated ADAMTS13 Activity is Associated with Poor Postoperative Outcome in Patients Undergoing Liver Resection.
    Haegele S; Fuxsteiner J; Pereyra D; Koeditz C; Rumpf B; Schuetz C; Schwarz C; Brostjan C; Gruenberger T; Starlinger P
    Sci Rep; 2018 Nov; 8(1):16823. PubMed ID: 30429491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. von Willebrand Factor Antigen Predicts Outcomes in Patients after Liver Resection of Hepatocellular Carcinoma.
    Schwarz C; Fitschek F; Mittlböck M; Saukel V; Bota S; Ferlitsch M; Ferlitsch A; Bodingbauer M; Kaczirek K
    Gut Liver; 2020 Mar; 14(2):218-224. PubMed ID: 30428508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between von Willebrand factor antigen, von Willebrand factor ristocetin cofactor activity and factor VIII activity in plasma.
    Lippi G; Franchini M; Salvagno GL; Montagnana M; Poli G; Guidi GC
    J Thromb Thrombolysis; 2008 Oct; 26(2):150-3. PubMed ID: 17786534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for serotonin as a relevant inducer of liver regeneration after liver resection in humans.
    Starlinger P; Assinger A; Haegele S; Wanek D; Zikeli S; Schauer D; Birner P; Fleischmann E; Gruenberger B; Brostjan C; Gruenberger T
    Hepatology; 2014 Jul; 60(1):257-66. PubMed ID: 24277679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Von Willebrand Factor Antigen Improves Risk Stratification for Patients with a Diagnosis of Resectable Hepatocellular Carcinoma.
    Pereyra D; Mandorfer M; Santol J; Gregory L; Koeditz C; Ortmayr G; Schuetz C; Rumpf B; Ammon D; Laengle J; Schwarz C; Jonas JP; Pinter M; Lindenlaub F; Tamandl D; Thiels C; Warner S; Smoot R; Truty M; Kendrick M; Nagorney D; Cleary S; Gruenberger T; Reiberger T; Starlinger P
    Ann Surg Oncol; 2024 Oct; 31(10):6526-6536. PubMed ID: 38896229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The von Willebrand Factor Facilitates Model for End-Stage Liver Disease-Independent Risk Stratification on the Waiting List for Liver Transplantation.
    Györi GP; Pereyra D; Rumpf B; Hackl H; Köditz C; Ortmayr G; Reiberger T; Trauner M; Berlakovich GA; Starlinger P
    Hepatology; 2020 Aug; 72(2):584-594. PubMed ID: 31773739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased von Willebrand factor ristocetin cofactor activity and increased ADAMTS13 antigen increase postoperative drainage after coronary artery bypass grafting.
    Mazur P; Plicner D; Zdziarska J; Sadowski J; Undas A
    Eur J Cardiothorac Surg; 2014 Feb; 45(2):e26-32. PubMed ID: 24351199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of von Willebrand factor in adult patients with congenital heart disease.
    Ohuchi H; Hayama Y; Miike H; Suzuki D; Nakajima K; Iwasa T; Konagai N; Sakaguchi H; Miyazaki A; Shiraishi I; Kurosaki KI; Nakai M
    Heart; 2020 Jun; 106(12):910-915. PubMed ID: 32188625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma von Willebrand factor levels predict in-hospital survival in patients with acute-on-chronic liver failure.
    Prasanna KS; Goel A; Amirtharaj GJ; Ramachandran A; Balasubramanian KA; Mackie I; Zachariah U; Sajith KG; Elias E; Eapen CE
    Indian J Gastroenterol; 2016 Nov; 35(6):432-440. PubMed ID: 27822882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial dysfunction marker von Willebrand factor antigen in haemodialysis patients: associations with pre-dialysis blood pressure and the acute phase response.
    Borawski J; Naumnik B; Pawlak K; Mysliwiec M
    Nephrol Dial Transplant; 2001 Jul; 16(7):1442-7. PubMed ID: 11427638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma thrombospondin 1 as a predictor of postoperative liver dysfunction.
    Starlinger P; Haegele S; Wanek D; Zikeli S; Schauer D; Alidzanovic L; Fleischmann E; Gruenberger B; Gruenberger T; Brostjan C
    Br J Surg; 2015 Jun; 102(7):826-36. PubMed ID: 25871570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profile of von Willebrand factor antigen and von Willebrand factor propeptide in an overall TIA and ischaemic stroke population and amongst subtypes.
    Tobin WO; Kinsella JA; Kavanagh GF; O'Donnell JS; McGrath RT; Tierney S; Egan B; Feeley TM; Coughlan T; Collins DR; O'Neill D; Murphy S; Lim SJ; Murphy RP; McCabe D
    J Neurol Sci; 2017 Apr; 375():404-410. PubMed ID: 28320178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis.
    Ferlitsch M; Reiberger T; Hoke M; Salzl P; Schwengerer B; Ulbrich G; Payer BA; Trauner M; Peck-Radosavljevic M; Ferlitsch A
    Hepatology; 2012 Oct; 56(4):1439-47. PubMed ID: 22532296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
    Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z
    Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Von Willebrand factor antigen for detection of hepatopulmonary syndrome in patients with cirrhosis.
    Horvatits T; Drolz A; Roedl K; Herkner H; Ferlitsch A; Perkmann T; Müller C; Trauner M; Schenk P; Fuhrmann V
    J Hepatol; 2014 Sep; 61(3):544-9. PubMed ID: 24798623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of transcutaneous aortic valve implantation on aortic valve disease-related hemostatic disorders involving von Willebrand factor.
    Caspar T; Jesel L; Desprez D; Grunebaum L; Samet H; Trinh A; Petit-Eisenmann H; Kindo M; Ohlmann P; Morel O
    Can J Cardiol; 2015 Jun; 31(6):738-43. PubMed ID: 25935884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient von Willebrand factor-mediated platelet influx stimulates liver regeneration after partial hepatectomy in mice.
    Kirschbaum M; Jenne CN; Veldhuis ZJ; Sjollema KA; Lenting PJ; Giepmans BNG; Porte RJ; Kubes P; Denis CV; Lisman T
    Liver Int; 2017 Nov; 37(11):1731-1737. PubMed ID: 28178387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Von Willebrand factor (VWF) activity VWF:Ac with VWF ristocetin cofactor activity VWF:RCo.
    Geisen U; Zieger B; Nakamura L; Weis A; Heinz J; Michiels JJ; Heilmann C
    Thromb Res; 2014 Aug; 134(2):246-50. PubMed ID: 24891215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.